Atención farmacéutica en enfermedades prevalentes (I). Gota e hiperuricemia. Farmacia Profesional. 2011; 25(1): 37-42.
Medida de adherencia al tratamiento en pacientes con hiperuricemia o gota. Ars Pharm. 2013; 54(3): 12-18.
Effectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot study. BMJ Open. 2014 Jan 10; 4(1): e003627. doi: 10.1136/bmjopen-2013-003627. PMID: 24413343; PMCID: PMC3902202.
Study Group of Community Pharmacists (SGCP) Investigators. Role of Community Pharmacies for the Detection of Potentially Inappropriate Xanthine Oxidase Inhibitor Prescriptions. Drugs Real World Outcomes. 2015 Mar; 2(1): 81-86. doi: 10.1007/s40801-015-0016-7. PMID: 27747614; PMCID: PMC4883203.
A Pharmacist-Staffed, Virtual Gout Management Clinic for Achieving Target Serum Uric Acid Levels: A Randomized Clinical Trial. Perm J. 2016 Summer; 20(3): 15-234. doi: 10.7812/TPP/15-234. Epub 2016 Jul 1. PMID: 27352414; PMCID: PMC4991910.
Pharmacists’ assessment and management of acute and chronic gout. Can Pharm J (Ott). 2018 Feb 9; 151(2): 107-113. doi: 10.1177/1715163518754916. PMID: 29531628; PMCID: PMC5843111.
Exploring current and potential roles of Australian community pharmacists in gout management: a qualitative study. BMC Fam Pract. 2018 May 9; 19(1): 54. doi: 10.1186/s12875-018-0744-3. PMID: 29743018; PMCID: PMC5941632.
Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial. Am J Med. 2019 Mar; 132(3): 354-361. doi: 10.1016/j.amjmed.2018.11.011. Epub 2018 Nov 29. PMID: 30503879; PMCID: PMC6399023.
Pharmacist-managed titration of urate-lowering therapy to streamline gout management. Rheumatol Int. 2019 Sep; 39(9): 1637-1641. doi: 10.1007/s00296-019-04333-5. Epub 2019 May 30. PMID: 31147732.
